| AF | Atrial fibrillation |
| AMI | Acute myocardial infarction |
| AMIpEF | Acute myocardial infarction with preserved ejection fraction |
| AMIrEF | Acute myocardial infarction with reduced ejection fraction |
| CA | Catheter ablation |
| CABG | Coronary artery bypass grafting surgery |
| CEM | Continuous electronic monitoring |
| CI | Confidence interval |
| CV death | Cardiovascular death |
| GRACE | Global Registry of Acute Coronary Events |
| HF | Heart failure |
| HFmrEF | HF with mildly reduced ejection fraction |
| HFpEF | HF with preserved ejection fraction |
| HFrEF | HF with reduced ejection fraction |
| HR | Hazard ratio |
| LVEDD | Left ventricular end-diastolic diameter |
| LVEF | Left ventricular ejection fraction |
| LVESD | Left ventricular end-systolic diameter |
| LVSD | Left ventricular systolic dysfunction |
| MACE | Major adverse cardiac events |
| NOAF | New-onset atrial fibrillation |
| NOAFCAMI-China | New-onset atrial fibrillation complicating acute myocardial infarction in China |
| NT-pro BNP | N-terminal pro-B-type natriuretic peptide |
| PCI | Percutaneous coronary intervention |
| RAS | Renin–angiotensin system |
| SD | Standard deviation |
| STEMI | ST-segment elevation myocardial infarction |
| TnT | Troponin T |